Dr. Reddy's Laboratories Ltd. closed 14.27% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...

Dr. Reddy's Laboratories Ltd. closed 16.92% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy’s Laboratories has received an order directing the company to pay more than ₹184 crore penalty under the CGST Act 2017. The authority has passed the order on the contention that the company ...

Q3 2025 Earnings Call Transcript January 23, 2025 Operator: Ladies and gentlemen, good day and welcome to the Quarter Three ...

Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) is expected to be announcing its earnings results on Wednesday, January ...

Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...

Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...

Dr. Reddy's shares in Friday's trade saw a sharp fall following the company's weak set of earnings for the December quarter.

The union budget 2025-26 emphasizes investment in technology, infrastructure, and healthcare. It includes simplifying tax ...

Pharmaceutical major Dr Reddy's Laboratories Ltd on Thursday (January 23) reported a 2.5% year-on-year (YoY) increase in net ...